OverviewSuggest Edit

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. More recently, the company has made the strategic decision to enter the oral film market and are in the process of implementing commercial oral film manufacturing capability. This enables IntelGenx to offer its partners a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing.

TypePublic
Founded2003
HQSaint-Laurent, CA
Websiteintelgenx.com
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2019)48(+27%)
Revenue (FY, 2019)$742 K(-59%)
Share Price (Feb 2021)C$0.4 (+5%)
Cybersecurity ratingFMore

Key People/Management at IntelGenx

Mark Nawacki

Mark Nawacki

Director
Andre Godin

Andre Godin

President and Chief Financial Officer
John S. Marinucci

John S. Marinucci

Director
Horst G. Zerbe

Horst G. Zerbe

Chairman & CEO
Show more

IntelGenx Office Locations

IntelGenx has an office in Saint-Laurent
Saint-Laurent, CA (HQ)
6420 Rue Abrams
Show all (1)

IntelGenx Financials and Metrics

IntelGenx Revenue

IntelGenx's revenue was reported to be $742 k in FY, 2019
USD

Revenue (Q2, 2020)

42.0k

Net income (Q2, 2020)

(1.6m)

EBIT (Q2, 2020)

(1.8m)

Market capitalization (8-Feb-2021)

48.0m

Closing stock price (8-Feb-2021)

0.4

Cash (30-Jun-2020)

3.1m

EV

53.0m
IntelGenx's current market capitalization is C$48 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

440.0k1.2m948.0k1.7m5.1m5.2m5.2m1.8m742.0k

Revenue growth, %

2%

Sales and marketing expense

13.0k

General and administrative expense

333.0k347.0k2.0m2.3m2.1m3.6m4.0m5.0m5.8m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

46.0k24.0k285.021.03.0k157.0547.0k100.0222.0k160.0k452.0k625.0k585.0k2.4m818.0k672.0k1.8m1.4m1.1m1.3m239.0k234.0k700.0k416.0k197.0k61.0k202.0k42.0k

Sales and marketing expense

3.0k4.0k

General and administrative expense

53.0k86.0k75.085.096.0k456.0394.0k491.0460.0k543.0k521.0k393.0k559.0k553.0k891.0k874.0k1.1m904.0k826.0k963.0k1.3m1.3m1.7m1.7m1.2m1.6m1.3m1.0m

R&D expense

305.0k360.0k445.0335.0312.0k167.048.0k191.0188.0k225.0k359.0k117.0k252.0k274.0k481.0k426.0k388.0k644.0k654.0k578.0k797.0k857.0k1.5m860.0k1.2m842.0k850.0k602.0k
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.5m2.1m5.0m4.4m2.9m612.0k1.6m11.0m1.9m

Accounts Receivable

263.0k1.3m144.0k652.0k1.1m1.0m623.0k815.0k381.0k

Prepaid Expenses

68.0k102.0k133.0k96.0k70.0k203.0k462.0k170.0k

Inventories

375.0k382.0k
USDQ2, 2011

Financial Leverage

1.1 x
Show all financial metrics

IntelGenx Cybersecurity Score

Cybersecurity ratingPremium dataset

F

49/100

SecurityScorecard logo

IntelGenx Online and Social Media Presence

Embed Graph

IntelGenx Company Culture

  • Overall Culture

    A+

    97/100

  • CEO Rating

    A+

    100/100

  • Compensation

    A+

    100/100

Learn more on Comparably

IntelGenx News and Updates

IntelGenx Files Provisional U.S. Patent Application for Novel VetaFilm™ High Loading Oral Film Platform

SAINT LAURENT, Quebec, Feb. 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it has filed a new provisional patent application at the United States Patent and Trademark Office entitled “High Loading Oral Film Formulation.”

IntelGenx Receives First Purchase Order For CBD Filmstrips From Heritage Cannabis

SAINT LAURENT, Quebec, Jan. 07, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced the execution of a definitive supply agreement (the “Agreement”) with Heritage Cannabis Holdings (“Heritage”), an international medical cannabis licensed prod…

IntelGenx Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films

SAINT LAURENT, Quebec, Nov. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,828,254, entitled “Oral film formulation for modulatin…

IntelGenx Announces Publication of a Study Evaluating Montelukast’s Effect on Neurological Aging

- Data Suggest Montelukast May Inhibit Mental Decline, Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease -

IntelGenx to Report Third Quarter 2020 Financial Results on November 12, 2020 – Conference Call to Follow

SAINT LAURENT, Quebec, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its third quarter 2020 financial results after market close on Thursday, November 12, 2020.

IntelGenx Announces Second Tranche Closing of Private Placement

SAINT LAURENT, Quebec, Oct. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) is pleased to announce that it has closed a private placement (the “Offering”) to certain investors in the United States of U.S.$532,000 principal amount of…
Show more

IntelGenx Frequently Asked Questions

  • When was IntelGenx founded?

    IntelGenx was founded in 2003.

  • Who are IntelGenx key executives?

    IntelGenx's key executives are Mark Nawacki, Andre Godin and John S. Marinucci.

  • How many employees does IntelGenx have?

    IntelGenx has 48 employees.

  • What is IntelGenx revenue?

    Latest IntelGenx annual revenue is $742 k.

  • What is IntelGenx revenue per employee?

    Latest IntelGenx revenue per employee is $15.5 k.

  • Who are IntelGenx competitors?

    Competitors of IntelGenx include Futura Medical, Horizon Therapeutics and Esperion Therapeutics.

  • Where is IntelGenx headquarters?

    IntelGenx headquarters is located at 6420 Rue Abrams, Saint-Laurent.

  • Where are IntelGenx offices?

    IntelGenx has an office in Saint-Laurent.

  • How many offices does IntelGenx have?

    IntelGenx has 1 office.